Honglin Xu

2.1k total citations
71 papers, 1.3k citations indexed

About

Honglin Xu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Honglin Xu has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 14 papers in Immunology and 10 papers in Oncology. Recurrent topics in Honglin Xu's work include Immune Cell Function and Interaction (8 papers), Traditional Chinese Medicine Analysis (7 papers) and Microtubule and mitosis dynamics (6 papers). Honglin Xu is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Traditional Chinese Medicine Analysis (7 papers) and Microtubule and mitosis dynamics (6 papers). Honglin Xu collaborates with scholars based in China, United States and Hong Kong. Honglin Xu's co-authors include Yingchun Zhou, Guang‐Hong Chen, Chyung‐Ru Wang, Lingpeng Xie, Bin Liu, Guoyong Zhang, Wenxiang Meng, Angela Colmone, Huijie Fan and Zhang‐Bin Tan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Honglin Xu

65 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Honglin Xu China 22 601 342 153 122 109 71 1.3k
Margaret M. Allaman United States 23 967 1.6× 353 1.0× 104 0.7× 102 0.8× 167 1.5× 48 1.9k
Weirong Wang China 22 1.0k 1.7× 450 1.3× 79 0.5× 66 0.5× 181 1.7× 66 1.7k
Heath C. Thomas United States 18 674 1.1× 195 0.6× 103 0.7× 195 1.6× 122 1.1× 31 1.4k
Xiuhui Li China 18 573 1.0× 201 0.6× 241 1.6× 57 0.5× 122 1.1× 52 1.2k
Ying-Wen Huang United States 23 681 1.1× 210 0.6× 146 1.0× 27 0.2× 179 1.6× 75 1.4k
Zhiguang Tu China 20 678 1.1× 231 0.7× 237 1.5× 272 2.2× 168 1.5× 69 1.5k
Ritu Chakravarti United States 20 650 1.1× 220 0.6× 65 0.4× 52 0.4× 78 0.7× 44 1.2k
Christianne Bandeira‐Melo Brazil 32 729 1.2× 807 2.4× 99 0.6× 40 0.3× 83 0.8× 62 2.3k
Yanrui Li Australia 16 628 1.0× 136 0.4× 305 2.0× 50 0.4× 104 1.0× 33 1.1k
Keiko Fukushima Japan 23 663 1.1× 379 1.1× 64 0.4× 210 1.7× 82 0.8× 55 1.3k

Countries citing papers authored by Honglin Xu

Since Specialization
Citations

This map shows the geographic impact of Honglin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglin Xu more than expected).

Fields of papers citing papers by Honglin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honglin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglin Xu. The network helps show where Honglin Xu may publish in the future.

Co-authorship network of co-authors of Honglin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Honglin Xu. A scholar is included among the top collaborators of Honglin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honglin Xu. Honglin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Honglin, Mingjie Pang, Guang‐Hong Chen, et al.. (2025). Panax ginseng exerts cardioprotective effect post myocardial infarction by attenuating myocardial fibrosis and inflammation through SIRT1 signaling pathways. Journal of Ginseng Research. 49(2). 197–207. 3 indexed citations
2.
Xu, Honglin, Feihu Zhou, Pablo Binder, et al.. (2025). Targeting P21‐Activated Kinase 2 as a Novel Therapeutic Approach to Mitigate Endoplasmic Reticulum Stress in Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association. 14(2). e035302–e035302. 1 indexed citations
3.
Xia, Jun, Yingjuan Liu, Wenqi He, et al.. (2025). Stabilisation of PRCP by deubiquitinase‐targeting chimera (DUBTAC) to replenish autophagy for ameliorating pathological cardiac hypertrophy. British Journal of Pharmacology. 182(21). 5317–5339. 1 indexed citations
4.
Chen, Xiaoting, Bin He, Honglin Xu, et al.. (2025). Piezo1 aggravates ischemia/reperfusion-induced acute kidney injury by Ca 2+ -dependent calpain/HIF-1α/Notch signaling. Renal Failure. 47(1). 2447801–2447801. 4 indexed citations
5.
Chen, Hongmei, Guoyong Zhang, Yuting Wu, et al.. (2024). Danggui Shaoyao San protects cyclophosphamide-induced premature ovarian failure by inhibiting apoptosis and oxidative stress through the regulation of the SIRT1/p53 signaling pathway. Journal of Ethnopharmacology. 323. 117718–117718. 18 indexed citations
6.
Pan, Xianmei, Honglin Xu, Zhifang Li, et al.. (2024). Guizhitongluo Tablet inhibits atherosclerosis and foam cell formation through regulating Piezo1/NLRP3 mediated macrophage pyroptosis. Phytomedicine. 132. 155827–155827. 14 indexed citations
7.
Zhou, Zhengrong, Aihua Mao, Honglin Xu, et al.. (2024). Deficiency of CAMSAP2 impairs olfaction and the morphogenesis of mitral cells. EMBO Reports. 25(7). 2861–2877.
8.
Xu, Honglin, et al.. (2024). Investigating TCR-pMHC interactions for TCRs without identified epitopes by constructing a computational pipeline. International Journal of Biological Macromolecules. 282(Pt 1). 136502–136502.
9.
Zhang, Rui, Honglin Xu, Zhengrong Zhou, et al.. (2023). CAMSAP1 role in orchestrating structure and dynamics of manchette microtubule minus-ends impacts male fertility during spermiogenesis. Proceedings of the National Academy of Sciences. 120(45). e2313787120–e2313787120. 13 indexed citations
10.
Wu, Yuting, Guoyong Zhang, Hua Yue, et al.. (2023). Ferrostatin-1 suppresses cardiomyocyte ferroptosis after myocardial infarction by activating Nrf2 signaling. Journal of Pharmacy and Pharmacology. 75(11). 1467–1477. 18 indexed citations
11.
Yue, Hua, Yuting Wu, Hongmei Chen, et al.. (2022). Buyang Huanwu decoction inhibits cardiomyocyte apoptosis after myocardial infarction by enhancing aldehyde dehydrogenase-2 activity and protein expression. Phytomedicine Plus. 2(4). 100364–100364. 1 indexed citations
12.
Tang, Yuanxiao, Zhilian Jia, Honglin Xu, Lin‐Tai Da, & Qiang Wu. (2021). Mechanism of REST/NRSF regulation of clustered protocadherin α genes. Nucleic Acids Research. 49(8). 4506–4521. 11 indexed citations
13.
Jiang, Xiaoli, Bo Deng, Min Cai, et al.. (2021). Dihydrotanshinone I inhibits the growth of hepatoma cells by direct inhibition of Src. Phytomedicine. 95. 153705–153705. 15 indexed citations
14.
Xie, Lingpeng, Yuting Wu, Chuying Zhou, et al.. (2021). Piceatannol protects against sepsis-induced myocardial dysfunction via direct inhibition of JAK2. International Immunopharmacology. 96. 107639–107639. 17 indexed citations
15.
Zhou, Zhengrong, Honglin Xu, Rui Zhang, et al.. (2020). CAMSAP1 breaks the homeostatic microtubule network to instruct neuronal polarity. Proceedings of the National Academy of Sciences. 117(36). 22193–22203. 22 indexed citations
16.
Li, Zhange, Honglin Xu, Xin Liu, et al.. (2020). GDF11 inhibits cardiomyocyte pyroptosis and exerts cardioprotection in acute myocardial infarction mice by upregulation of transcription factor HOXA3. Cell Death and Disease. 11(10). 917–917. 59 indexed citations
17.
Zimmer, Michael I., Hanh Nguyen, Bin Wang, et al.. (2009). Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells. Proceedings of the National Academy of Sciences. 106(6). 1909–1914. 28 indexed citations
18.
Wang, Tong‐Min, Luqiu Chen, Emily Ahmed, et al.. (2008). Prevention of Allograft Tolerance by Bacterial Infection with Listeria monocytogenes. The Journal of Immunology. 180(9). 5991–5999. 73 indexed citations
19.
Zimmer, Michael I., Angela Colmone, Kyrie Felio, et al.. (2006). A Cell-Type Specific CD1d Expression Program Modulates Invariant NKT Cell Development and Function. The Journal of Immunology. 176(3). 1421–1430. 36 indexed citations
20.
Xu, Honglin, Taehoon Chun, Angela Colmone, Hanh Nguyen, & Chyung‐Ru Wang. (2003). Expression of CD1d Under the Control of a MHC Class Ia Promoter Skews the Development of NKT Cells, But Not CD8+ T Cells. The Journal of Immunology. 171(8). 4105–4112. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret M. Allaman Breakdown of academic impact, for papers by Weirong Wang Breakdown of academic impact, for papers by Heath C. Thomas Breakdown of academic impact, for papers by Xiuhui Li Breakdown of academic impact, for papers by Ying-Wen Huang Breakdown of academic impact, for papers by Zhiguang Tu Breakdown of academic impact, for papers by Ritu Chakravarti Breakdown of academic impact, for papers by Christianne Bandeira‐Melo Breakdown of academic impact, for papers by Yanrui Li Breakdown of academic impact, for papers by Keiko Fukushima
Rankless by CCL
2026